![Raymond de Vre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raymond de Vre
Directeur/Membre du Conseil chez
CODEXIS, INC.
Fortune : 234 926 $ au 31/05/2026
Profil
Raymond de Vre currently works at PolyPeptide Laboratories A, as Chairman, Aurigene Oncology Ltd., as Director, Codexis, Inc., as Independent Director from 2024, and EQL Pharma AB, as Independent Director from 2025.
Dr. de Vre also formerly worked at PolyPeptide Group AG, as Chief Executive Officer from 2021 to 2023, McKinsey & Co., Inc., as Partner from 2004 to 2011, and Reddys Medicare Laboratories India Pvt Ltd., as Senior Vice President-Global Business Operations from 2012 to 2021.
Dr. de Vre received his doctorate degree from Stanford University and graduate degree from Université Libre de Bruxelles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CODEXIS, INC. 0,09% | 11/06/2026 | 84 811 ( 0,09% ) | 234 926 $ | 31/05/2026 |
Dernières actualités sur Raymond de Vre
Postes actifs de Raymond de Vre
| Sociétés | Poste | Début |
|---|---|---|
| CODEXIS, INC. | Directeur/Membre du Conseil | 07/11/2024 |
| EQL PHARMA AB | Directeur/Membre du Conseil | 01/01/2025 |
Aurigene Oncology Ltd.
 Aurigene Oncology Ltd. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Directeur/Membre du Conseil | - |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Président | - |
Anciens postes connus de Raymond de Vre
| Sociétés | Poste | Fin |
|---|---|---|
| POLYPEPTIDE GROUP AG | Directeur Général | 30/01/2023 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01/01/2011 |
Formation de Raymond de Vre
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQL Pharma AB
 EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Aurigene Oncology Ltd.
Aurigene Oncology Ltd. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Health Technology |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Process Industries |
PolyPeptide Group AG
 PolyPeptide Group AG BiotechnologyHealth Technology Manufactures polypeptide and custom peptide synthesis | Health Technology |
